Navigation Links
Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results


showed evidence of significant tumor regression relative to the

untreated control mice, while the other showed a diminished rate of

tumor growth along with some regression.

-- Initial field trials conducted with ArborGen, LLC over a three-year

period in certain species of trees have concluded and the trees have

been harvested for wood quality assessment. Preliminary data from the

field trials show significantly enhanced growth rates in some of the

trees relative to controls. The Company and ArborGen have selected

promising genetic lines which are now being prepared for additional

field trials.

Bruce Galton, President and Chief Executive Officer of the Company, said, "We continue to progress our human health programs and believe we have positive preclinical results in our multiple myeloma studies and pancreatic islet cell research. Senesco is working closely with our contract research organization in evaluating materials and planning the work ahead for our multiple myeloma program. In addition, our agricultural licensees have initiated research with our technology in crops such as corn, soy, rice, canola and cotton. We continue banana field trials with our joint venture partner, Rahan Meristem. Our technology provides a very broad platform of applications for human health in oncology and inflammatory diseases and across a variety of food and non-food agricultural crops."

Revenue of $79,167 for the three-month period ended March 31, 2008 consisted of milestone payments and the amortized portion of previous milestone payments received in connection with certain license agreements. During the three-month period ended March 31, 2007, revenue of $6,250 consisted of the amortized portion of previous milestone payments received in connection with certain development and license agreements.

Research and development expenses during the three-month period ended March 31,

SOURCE Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
2. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
5. Adnavance Technologies Inc. Appoints Christian P. Valcke, Ph.D., to Its Scientific Advisory Board
6. Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant
7. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
8. Veran Medical Technologies Secures $4.75M in First Institutional Funding
9. Neurobiological Technologies Reports Third Quarter Financial Results
10. InSet Technologies Appoints Jon Tremmel to its Board of Directors
11. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
Post Your Comments:
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: , In ... team and Board, which launched the company’s new strategy ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, ... Strategy. In this role, Michelle will work with current and ... the development of iLab products. Her main goal will be ... the scientific community by offering the most advanced, user-friendly, and ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), ... solutions for patients, physicians, the biopharmaceutical industry, regulators, ... the signing of a three-year Research Collaboration Agreement ... (FDA). This initiative is designed to generate ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Spherix Incorporated (Nasdaq: SPEX ), an ... and atherosclerosis; and providers of technical and regulatory consulting ... announced that it will host an investment community conference ... December 9, to discuss results of the Company,s Phase ...
... 6, 2010 Viruses have a bad rep—and rightly ... precisely replicate itself makes it a destructive scourge to ... researchers at the University of Maryland,s A. James Clark ... Resources, brought together by Professor Reza Ghodssi, is turning ...
... Todd Hutchings has assumed leadership of Egon Zehnder ... who led the practice, will continue at the firm ... executives. In his new role, Mr. Hutchings ... with boards and providing the full array of functional ...
Cached Biology Technology:Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time 2Bad Virus Put to Good Use: Breakthrough Batteries 2Bad Virus Put to Good Use: Breakthrough Batteries 3Bad Virus Put to Good Use: Breakthrough Batteries 4Bad Virus Put to Good Use: Breakthrough Batteries 5Bad Virus Put to Good Use: Breakthrough Batteries 6Egon Zehnder International Names Todd Hutchings to Lead Life Sciences Practice Group 2
(Date:4/16/2014)... of Nicaragua,s legal, artisanal green sea turtle fishery has ... of turtles in what may have become an unsustainable ... Society and University of Florida. , During the research ... turtles were killed between 1991 and 2011, with catch ...
(Date:4/16/2014)... Florida State University researchers have identified a new ... bone density and muscle mass with obesity. , "It ... were the better your bones would be because the ... Hazel Stiebeling Professor of Nutrition at Florida State. "But, ...
(Date:4/16/2014)... eyes up, and you cannot lift your upper eyelid. You walk ... look straight when they are rolled down in the eye socket. ... normal position of their head. In order to correct this condition, ... paper published in the April 16 print issue of the journal ...
Breaking Biology News(10 mins):Declining catch rates in Caribbean green turtle fishery may be result of overfishing 2Declining catch rates in Caribbean green turtle fishery may be result of overfishing 3Researchers: Obesity can amplify bone and muscle loss 2Researchers track down cause of eye mobility disorder 2
... as a model to study embryo formation, scientists report ... of a protein called Bicoid is vital to normal ... by the journal Dec. 19, the study shows how ... identified protein the researchers named Fates-shifted (Fsd). Without the ...
... Society has announced the winners of its second annual ... Annual Meeting at the Baltimore Convention Center in Baltimore, ... Professional Opportunities for Women, has initiated these travel fellowships ... their participation at the Meeting. The recipients of ...
... The prolonged, extensive emission of greenhouse gases over ... ocean life, according to a study by UC Merced ... emissions exacerbated by the burning of fossil fuels ... more acidic, and Beman,s study shows that the increased ...
Cached Biology News:Fruit fly study digs deeper into poorly understood details of forming embryos 2Biophysical Society announces winners of 2011 CPOW Travel Awards 2Rising greenhouse gases profoundly impact microscopic marine life 2
Newborn Calf Serum US Origin...
SPDP-Trinitrophenol (TNP) Bovine Serum Albumin...
Acrylamide, 500 g. Assay: > 99.9%, acrylic acid: < 0.001%. Conductivity (35%): < 2 umhos/cm.Risks: 45, 46, 48, 23, 24, 25 ; Safety Precautions: 53, 44. Category: Nucleotides & Enzymes & Biochemicals...
HRP Monoclonal-Goat Diluent - 5X Concentrate, 25 mL...
Biology Products: